Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1 Ovarian Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Temozolomide 7 Vincristine 5 Cyclophosphamide 5 X-Rays 4 Specimen Handling 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Irinotecan 4 cabozantinib 3 Ifosfamide 3 Etoposide 3 Doxorubicin 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 liposomal doxorubicin 2 ivosidenib 2 fludarabine 2 Topotecan 2 Radiation 2 Nuclear Medicine Department, Hospital 2 LY3023414 2 Eflornithine 2 Congresses as Topic 2 trifluridine tipiracil drug combination 1 talazoparib 1 silmitasertib 1 romiplostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × romiplostim × 90 days × Clear all

NCT07048249 2026-03-18

Single Arm Romiplostim to Prevent CIT

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡